Skip to main content
Sugentech, Inc. logo

Sugentech, Inc. — Investor Relations & Filings

Ticker · 253840 ISIN · KR7253840003 KO Manufacturing
Open in API
Filings indexed 297 across all filing types
Latest filing 2021-02-10 Earnings Release
Country KR South Korea
Listing KO 253840

About Sugentech, Inc.

https://www.sugentech.com/en/

Sugentech, Inc. is an in-vitro diagnostics (IVD) company that develops and commercializes diagnostic solutions by integrating biotechnology, nanotechnology, and information technology. The company's product portfolio serves diverse healthcare settings, from large hospitals and laboratories to smaller clinics and home users. Key offerings include automated multi-immunoblot systems, point-of-care testing (POCT) platforms, and self-diagnostic kits for personal use, such as ovulation and pregnancy tests. Sugentech leverages proprietary technologies in developing high-level antibodies and advanced nanoparticles to create highly sensitive and precise immunochemical assays, underpinning its digital healthcare diagnostic platform for personalized medicine.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Sugentech) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report preliminary financial results before the final audit. Since it provides key financial highlights and reasons for the change rather than being a full annual report or a simple announcement of a report's availability, it falls under the category of Earnings Release (ER). FY 2020
2021-02-10 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the closure of the shareholder register (stock transfer suspension) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal regulatory notice of a corporate action. Given it is a specific regulatory announcement that does not fit into the other categories like dividend or share issuance, it is classified as a general regulatory filing.
2020-12-14 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Sugentech Inc. for the 3rd quarter of 2020. It contains detailed financial information, business descriptions, capital changes, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-13 Korean
파생상품거래손실발생
Capital/Financing Update Classification · 100% confidence The document is a regulatory disclosure from a Korean company (Sugentech) regarding a 'Derivative Trading Loss' (파생상품거래손실발생). This type of disclosure is a mandatory regulatory filing in the Korean market (KRX) to inform investors about significant financial events that impact equity or financial statements. Since it does not fit into specific categories like M&A, dividends, or share repurchases, and is a formal regulatory announcement, it is classified as a Regulatory Filing (RNS).
2020-11-13 Korean
기타경영사항(특허권취득)(자율공시)(스트립의 전처리 및 분석이 가능한 스트립 자동 분석시스템)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from a Korean company (Sugentech) regarding the acquisition of a patent. It follows the standard format for 'Other Management Matters' (기타 경영사항) filings in the Korean market. Since it does not fit into specific categories like financial reports, dividends, or director dealings, and is a formal regulatory announcement, it falls under the 'Regulatory Filings' (RNS) category.
2020-11-03 Korean
수시공시의무관련사항(공정공시)
Regulatory Filings Classification · 95% confidence The document is a 'Fair Disclosure' (공정공시) filing from Sugentech regarding a supply contract for COVID-19 diagnostic kits. It details the counterparty, contract duration, and product types. Since it is a regulatory announcement of a business development that does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2020-11-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.